Someone with a medical knowledge of what significant actually means in any new treatment of any disease weather it’s cancer, heart,kidney etc. MRKR has multiple clinical testing trials started, and that’s great but if someone could tell us investors what is going to constitute a result that will qualify as significant in terms treating patients with results that are measured as successful. Second stage pancreatic results had one research doctor for MRKR so excited he could hardly hold back his excitement about the results. My question is who will ultimately decide if this drug is significant to get approval for treatment.
News 
Market Data 
Discover 
